Mohammed W. Al-Rabia
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria 4
-
- Drug-Induced Hepatotoxicity and Protection 4
-
- Immune Cell Function and Interaction 3
-
- Eosinophilic Disorders and Syndromes 4
-
- Medical Education and Admissions 4
- Innovations in Medical Education 4
-
- Bacterial biofilms and quorum sensing 3
-
- COVID-19 diagnosis using AI 3
- Co-authors
- Hani Z. AsfourNabil A. AlhakamyDarren W. SextonGarry M. WalshMorgan G. BlaylockAhmed AldarmahiOsama A. A. AhmedGamal A. Mohamed
- Journals
- Infection and Drug Resistance (3 papers)Antioxidants (2 papers)Clinical & Experimental Allergy (2 papers)
- Partner nations
- Saudi ArabiaEgyptUnited Kingdom
In The Last Decade
Mohammed W. Al-Rabia
64 papers receiving 632 citations
Hit Papers
Peers
Comparison fields: 5 of 123
- Molecular Medicine 52
- Applied Microbiology and Biotechnology 16
- Microbiology 30
- Pharmacology 37
- Immunology 89
Countries citing papers authored by Mohammed W. Al-Rabia
This map shows the geographic impact of Mohammed W. Al-Rabia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammed W. Al-Rabia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammed W. Al-Rabia more than expected).
Fields of papers citing papers by Mohammed W. Al-Rabia
This network shows the impact of papers produced by Mohammed W. Al-Rabia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammed W. Al-Rabia. The network helps show where Mohammed W. Al-Rabia may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mohammed W. Al-Rabia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 2 | |
| 4 | 2024 | 5 | |
| 5 | 2024 | 12 | |
| 6 | 2024 | 6 | |
| 7 | 2024 | 5 | |
| 8 | 2024 | 11 | |
| 9 | 2023 | 9 | |
| 10 | 2023 | 4 | |
| 11 | 2022 | 4 | |
| 12 | 2022 | 21 | |
| 13 | 2022 | 18 | |
| 14 | 2022 | 5 | |
| 15 | 2021 | 19 | |
| 16 | 2021 | 33 | |
| 17 | 2020 | 34 | |
| 18 | 2015 | 1 | |
| 19 | Acute paraplegia caused by Schistosoma mansoni. | 2014 | 3 |
| 20 | 2004 | 38 |
About Mohammed W. Al-Rabia
Mohammed W. Al-Rabia is a scholar working on Molecular Medicine, Toxicology and Complementary and alternative medicine, having authored 71 papers that have together received 646 indexed citations. Recurring topics across this work include Eosinophilic Disorders and Syndromes (4 papers), Antibiotic Resistance in Bacteria (4 papers), Drug-Induced Hepatotoxicity and Protection (4 papers), Medical Education and Admissions (4 papers), Innovations in Medical Education (4 papers), Bacterial biofilms and quorum sensing (3 papers), COVID-19 diagnosis using AI (3 papers) and Immune Cell Function and Interaction (3 papers). The work is most often cited by research in Molecular Medicine (52 citations), Applied Microbiology and Biotechnology (16 citations) and Microbiology (30 citations). Mohammed W. Al-Rabia has collaborated with scholars based in Saudi Arabia, Egypt and United Kingdom. Frequent co-authors include Hani Z. Asfour, Nabil A. Alhakamy, Darren W. Sexton, Garry M. Walsh, Morgan G. Blaylock, Ahmed Aldarmahi, Osama A. A. Ahmed, Gamal A. Mohamed, Sabrin R. M. Ibrahim and Usama A. Fahmy. Their work appears in journals such as Infection and Drug Resistance, Antioxidants, Clinical & Experimental Allergy, Pharmaceutics and Drug Delivery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.